Accelerating the discovery of disease-specific autoantigens

Unlocking valuable autoantigen insight

• ORVAR identifies all possible autoantigens within a patient cohort at a given time that are associated with a disease.
• We then use our patented KREX^® technology to clone, express, and attach all autoantigens to create and validate a Sengenics protein array.
• This protein array serves as a validated, true positive, disease-specific autoantigen library.
• Applications include the discovery of autoantibody signatures for development of early diagnostics, patient stratification, and drug response prediction.